203 related articles for article (PubMed ID: 17172431)
1. Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells.
Zhao R; Domann FE; Zhong W
Mol Cancer Ther; 2006 Dec; 5(12):3275-84. PubMed ID: 17172431
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells.
Zhao R; Xiang N; Domann FE; Zhong W
Cancer Res; 2006 Feb; 66(4):2296-304. PubMed ID: 16489034
[TBL] [Abstract][Full Text] [Related]
3. Methylselenol generated from selenomethionine by methioninase downregulates integrin expression and induces caspase-mediated apoptosis of B16F10 melanoma cells.
Kim A; Oh JH; Park JM; Chung AS
J Cell Physiol; 2007 Aug; 212(2):386-400. PubMed ID: 17348006
[TBL] [Abstract][Full Text] [Related]
4. Methioninase Gene Therapy.
Hoffman RM; Miki K; Al-Refaie W; Xu M; Tan Y
Methods Mol Biol; 2019; 1866():173-197. PubMed ID: 30725416
[TBL] [Abstract][Full Text] [Related]
5. Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway.
Hu H; Jiang C; Schuster T; Li GX; Daniel PT; Lü J
Mol Cancer Ther; 2006 Jul; 5(7):1873-82. PubMed ID: 16891474
[TBL] [Abstract][Full Text] [Related]
6. Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells.
Xiang N; Zhao R; Zhong W
Cancer Chemother Pharmacol; 2009 Jan; 63(2):351-62. PubMed ID: 18379781
[TBL] [Abstract][Full Text] [Related]
7. Methioninase gene therapy with selenomethionine induces apoptosis in bcl-2-overproducing lung cancer cells.
Yamamoto N; Gupta A; Xu M; Miki K; Tsujimoto Y; Tsuchiya H; Tomita K; Moossa AR; Hoffman RM
Cancer Gene Ther; 2003 Jun; 10(6):445-50. PubMed ID: 12768189
[TBL] [Abstract][Full Text] [Related]
8. Selenium effects on prostate cell growth.
Menter DG; Sabichi AL; Lippman SM
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1171-82. PubMed ID: 11097224
[TBL] [Abstract][Full Text] [Related]
9. Differential apoptotic response of human cancer cells to organoselenium compounds.
Suzuki M; Endo M; Shinohara F; Echigo S; Rikiishi H
Cancer Chemother Pharmacol; 2010 Aug; 66(3):475-84. PubMed ID: 19940991
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of methyl methanesulfonate-induced base excision repair in the presence of selenomethionine on p53-dependent pathway.
Jung HJ; Lee JH; Seo YR
J Med Food; 2009 Apr; 12(2):340-4. PubMed ID: 19459735
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, immunogenicity and anticancer efficiency of Aspergillus flavipes L-methioninase.
El-Sayed AS; Shouman SA; Nassrat HM
Enzyme Microb Technol; 2012 Sep; 51(4):200-10. PubMed ID: 22883554
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of p53 and reductions in XIAP abundance promote the apoptosis of prostate cancer cells.
Mohapatra S; Chu B; Zhao X; Pledger WJ
Cancer Res; 2005 Sep; 65(17):7717-23. PubMed ID: 16140939
[TBL] [Abstract][Full Text] [Related]
14. Superoxide-hydrogen peroxide genetic imbalance modulates differentially the oxidative metabolism on human peripheral blood mononuclear cells exposed to seleno-L-methionine.
Schott KL; Assmann CE; Barbisan F; Azzolin VF; Bonadiman B; Duarte MMMF; Machado AK; da Cruz IBM
Chem Biol Interact; 2017 Aug; 273():18-27. PubMed ID: 28495429
[TBL] [Abstract][Full Text] [Related]
15. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism.
Seo YR; Kelley MR; Smith ML
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14548-53. PubMed ID: 12357032
[TBL] [Abstract][Full Text] [Related]
16. Methioninase and selenomethionine but not Se-methylselenocysteine generate methylselenol and superoxide in an in vitro chemiluminescent assay: implications for the nutritional carcinostatic activity of selenoamino acids.
Spallholz JE; Palace VP; Reid TW
Biochem Pharmacol; 2004 Feb; 67(3):547-54. PubMed ID: 15037206
[TBL] [Abstract][Full Text] [Related]
17. Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells.
Li GX; Hu H; Jiang C; Schuster T; Lü J
Int J Cancer; 2007 May; 120(9):2034-43. PubMed ID: 17230520
[TBL] [Abstract][Full Text] [Related]
18. A novel chemopreventive mechanism of selenomethionine: enhancement of APE1 enzyme activity via a Gadd45a, PCNA and APE1 protein complex that regulates p53-mediated base excision repair.
Jung HJ; Kim HL; Kim YJ; Weon JI; Seo YR
Oncol Rep; 2013 Oct; 30(4):1581-6. PubMed ID: 23846616
[TBL] [Abstract][Full Text] [Related]
19. Enhanced redox factor 1 (REF1)-modulated p53 stabilization and JNK1 dissociation in response to selenomethionine.
Jung HJ; Kim HL; Seo YR
Anticancer Res; 2013 Sep; 33(9):3645-51. PubMed ID: 24023291
[TBL] [Abstract][Full Text] [Related]
20. Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex.
Fischer JL; Lancia JK; Mathur A; Smith ML
Anticancer Res; 2006; 26(2A):899-904. PubMed ID: 16619485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
